<SEC-DOCUMENT>0001969223-24-000575.txt : 20240808
<SEC-HEADER>0001969223-24-000575.hdr.sgml : 20240808
<ACCEPTANCE-DATETIME>20240808133428
ACCESSION NUMBER:		0001969223-24-000575
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20240808
DATE AS OF CHANGE:		20240808

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
		CENTRAL INDEX KEY:			0001100682
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				061397316
		FISCAL YEAR END:			1228

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-15943
		FILM NUMBER:		241187345

	BUSINESS ADDRESS:	
		STREET 1:		251 BALLARDVALE ST
		CITY:			WILMINGTON
		STATE:			MA
		ZIP:			01887
		BUSINESS PHONE:		781-222-6000

	MAIL ADDRESS:	
		STREET 1:		251 BALLARDVALE ST
		CITY:			WILMINGTON
		STATE:			MA
		ZIP:			01887

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHARLES RIVER LABORATORIES INTERNATIONAL INC
		DATE OF NAME CHANGE:	20000605

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHARLES RIVER LABORATORIES HOLDINGS INC
		DATE OF NAME CHANGE:	19991208

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LaPlume Joseph W
		CENTRAL INDEX KEY:			0001767215
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		251 BALLARDVALE STREET
		CITY:			WILMINGTON
		STATE:			MA
		ZIP:			01887
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001767215</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001100682</issuerCik>
      <issuerName>Charles River Laboratories</issuerName>
      <secFileNumber>001-15943</secFileNumber>
      <issuerAddress>
        <com:street1>251 Ballardvale Street</com:street1>
        <com:city>Wilmington</com:city>
        <com:stateOrCountry>MA</com:stateOrCountry>
        <com:zipCode>01887</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>781-222-6273</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Joseph LaPlume</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>UBS Financial Services Inc</name>
        <address>
          <com:street1>1000 Harbor Blvd</com:street1>
          <com:street2>3rd Floor</com:street2>
          <com:city>Weehawken</com:city>
          <com:stateOrCountry>NJ</com:stateOrCountry>
          <com:zipCode>07086</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>1780</noOfUnitsSold>
      <aggregateMarketValue>350000</aggregateMarketValue>
      <noOfUnitsOutstanding>51630726</noOfUnitsOutstanding>
      <approxSaleDate>08/08/2024</approxSaleDate>
      <securitiesExchangeName>NYSE</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>01/28/2022</acquiredDate>
      <natureOfAcquisitionTransaction>PSU</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Charles River Laboratories</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>1780</amountOfSecuritiesAcquired>
      <paymentDate>01/28/2022</paymentDate>
      <natureOfPayment>CASH</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Joseph LaPlume</name>
        <address>
          <com:street1>C/O Charles River Laboratories</com:street1>
          <com:street2>251 Ballardvale Street</com:street2>
          <com:city>Wilmington</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>01887</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Charles River Laboratories</securitiesClassTitle>
      <saleDate>05/10/2024</saleDate>
      <amountOfSecuritiesSold>1304</amountOfSecuritiesSold>
      <grossProceeds>295943</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>08/08/2024</noticeDate>
      <signature>/s/ UBS Financial Services Inc, as attorney-in-fact for Joseph LaPlume</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
